written on 07.04.2014

Sun Pharma hopes to turn fortunes of Ranbaxy around with $3.2B buyout


Sun Pharmaceutical has been shopping for deals that would give it more exposure to the U.S. market, and now it has pulled off a stunner. The Indian drugmaker will pay $3.2 million to buy competitor Ranbaxy Laboratories, a company with serious issues but one with big potential in the world's largest market.